Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
life sciences
national blog main
boston top stories
drugs
fda
national top stories
new york blog main
new york top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
akcea therapeutics
allopregnanolone
alprazolam
amgen
anylam pharmaceuticals
biotech
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
cancer
cardiomyopathy
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drug enforcement administration
eli lilly
entrectinib
express scripts
What
fda
5
×
oks
5
×
drug
approved
new
cancer
genetic
medicine
second
acute
addresses
agency
ago
akcea
allow
alnylam
amyloidosis
approval
attr
available
battle
brexanolone
causes
condition
debilitating
decades
deeper
depression
devastating
disease
disorder
dna
dose
eli
extra
fast
federal
fingerprint
friday
giant
Language
unset
Current search:
fda
×
oks
×
@wired.com
2 years ago
The FDA OKs an Extra Vaccine Dose for Immunosuppressed People
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues